Polyether Ether Ketone (PEEK); High-Performance Thermoplastic Used In Wide Range of Applications

Polyether Ether Ketone (PEEK)
Polyether Ether Ketone (PEEK)

Polyether Ether Ketone (PEEK) is an aromatic polyether containing repeating monomers of ketone group. It is a high performance engineering thermoplastic. It has excellent mechanical, electrical, and chemical properties. PEEK is used in a wide range of applications. The application prospects of PEEK in the field of orthopedics, dental implants, prosthodontics, and oral repair are promising. Polyether ether ketone is an effective, non-toxic alternative to metals, particularly titanium.

PEEK is also considered as an effective replacement for stainless steel in impeller wheels of regenerative pumps. In addition to its mechanical and thermal properties, it also has good biocompatibility. These characteristics make it an ideal material for use in medical devices and for the manufacture of complex implants. PEEK based materials are becoming an important group of biomaterials used for bone and cartilage replacement as well as in a large number of diverse medical fields.

Polyether Ether Ketone (PEEK) Market has been increasingly employed as biomaterials for prosthesis, orthopaedic, and spinal implants.

PEEK can overcome some of the limitations of metal implants such as stress shielding and metal allergy. Polyether ether ketone is currently used as an orthopedic implant in clinical practice and has achieved good results. PEEK is a highly-resistant and heat-resistant thermoplastic, and can withstand high temperatures without permanently deforming. It is an important attribute for use in engine compartments.

It is ALSO suitable for repeated exposure to food. PEEK carries a V-0 flammability rating and exhibits very low smoke and toxic gas emission when exposed to flame. Moreover, Polyether Ether Ketone (PEEK) is approved by the Food and Drug Administration (FDA) for food contact applications (since 1998). All unfilled PEEK grades comply with the FDA regulation 21 CFR 177.2415 for repeated food contact. PEEK is now finding use in food contact applications, following approval from the U.S. FDA.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more

Patient-Centered Medical Home; Is Used To Offer High-Standard, Inexpensive Primary Care

Image
Patient-Centered Medical Home The Patient-Centered Medical Home is a care model in which individuals are involved in a direct association with a chosen physician who organizes a supportive team of hospital experts, takes cooperative accountability for the comprehensive incorporated care offered to the patient, and sponsors and arranges suitable care with other professional physicians and community sources as per requirements. Use of PCMH develop disciplinary care teams to enhance care management and care administration of patient populaces focusing to increase safety, efficacy and standard in patient care. PCMH practices can enhance care and take benefits of private or public inducement payments that are offered to patients. The Patient Protection and Affordable Care Act (ACA) provides extra federal expenditure to regions for health homes helping Medicaid receivers. Supplier groups and hospitals can visit their federal and state officials and private insurers’ websites for data on exp
Read more